Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 166

1.

Effects of Elevated Parathyroid Hormone Levels on Muscle Health, Postural Stability and Quality of Life in Vitamin D-Insufficient Healthy Women: A Cross-Sectional Study.

Bislev LS, Langagergaard Rødbro L, Sikjær T, Rejnmark L.

Calcif Tissue Int. 2019 Sep 14. doi: 10.1007/s00223-019-00612-2. [Epub ahead of print]

PMID:
31522253
2.

Expanding the spectrum of genetic variants in the calcium-sensing receptor (CASR) gene in hypercalcemic individuals.

Nissen PH, Rejnmark L.

Clin Endocrinol (Oxf). 2019 Nov;91(5):683-690. doi: 10.1111/cen.14078. Epub 2019 Sep 9.

PMID:
31433865
3.

Effect of 9 months of vitamin D supplementation on arterial stiffness and blood pressure in Graves' disease: a randomized clinical trial.

Grove-Laugesen D, Malmstroem S, Ebbehoj E, Riis AL, Watt T, Hansen KW, Rejnmark L.

Endocrine. 2019 Jul 6. doi: 10.1007/s12020-019-01997-8. [Epub ahead of print]

PMID:
31280470
4.

MANAGEMENT OF ENDOCRINE DISEASE: Unmet therapeutic, educational and scientific needs in parathyroid disorders.

Bollerslev J, Schalin-Jantti C, Rejnmark L, Siggelkow H, Morreau H, Thakker RV, Sitges-Serra A, Cetani F, Marcocci C; PARAT Workshop Group.

Eur J Endocrinol. 2019 Sep 1;181(3):P1-P19. doi: 10.1530/EJE-19-0316. Epub 2019 Jun 1. Review.

5.

Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia.

Haffner D, Emma F, Eastwood DM, Duplan MB, Bacchetta J, Schnabel D, Wicart P, Bockenhauer D, Santos F, Levtchenko E, Harvengt P, Kirchhoff M, Di Rocco F, Chaussain C, Brandi ML, Savendahl L, Briot K, Kamenicky P, Rejnmark L, Linglart A.

Nat Rev Nephrol. 2019 Jul;15(7):435-455. doi: 10.1038/s41581-019-0152-5. Review.

PMID:
31068690
6.

25(OH)D3 and 1.25(OH)2D3 inhibits TNF-α expression in human monocyte derived macrophages.

Rafique A, Rejnmark L, Heickendorff L, Møller HJ.

PLoS One. 2019 Apr 12;14(4):e0215383. doi: 10.1371/journal.pone.0215383. eCollection 2019.

7.

T-score differences and nonprogression in lumbar vertebrae as predictors of vertebral fractures.

Lajlev SE, Rejnmark L, Harsløf T.

Clin Endocrinol (Oxf). 2019 Jul;91(1):58-62. doi: 10.1111/cen.13987. Epub 2019 Apr 23.

PMID:
30973641
8.

Muscle Performance and Postural Stability Are Reduced in Patients with Newly Diagnosed Graves' Disease.

Malmstroem S, Grove-Laugesen D, Riis AL, Bruun BJ, Ebbehoj E, Hansen KW, Watt T, Rejnmark L.

Thyroid. 2019 Jun;29(6):783-789. doi: 10.1089/thy.2018.0318. Epub 2019 Apr 11.

PMID:
30880636
9.

Effect of Parathyroidectomy on Cardiovascular Risk Factors in Primary Hyperparathyroidism: A Randomized Clinical Trial.

Ejlsmark-Svensson H, Rolighed L, Rejnmark L.

J Clin Endocrinol Metab. 2019 Aug 1;104(8):3223-3232. doi: 10.1210/jc.2018-02456.

PMID:
30860588
10.

Huge variations in definition and reported incidence of postsurgical hypoparathyroidism: a systematic review.

Harsløf T, Rolighed L, Rejnmark L.

Endocrine. 2019 Apr;64(1):176-183. doi: 10.1007/s12020-019-01858-4. Epub 2019 Feb 20.

PMID:
30788669
11.

Effect of Genetically Low 25-Hydroxyvitamin D on Mortality Risk: Mendelian Randomization Analysis in 3 Large European Cohorts.

Aspelund T, Grübler MR, Smith AV, Gudmundsson EF, Keppel M, Cotch MF, Harris TB, Jorde R, Grimnes G, Joakimsen R, Schirmer H, Wilsgaard T, Mathiesen EB, Njølstad I, Løchen ML, März W, Kleber ME, Tomaschitz A, Grove-Laugesen D, Rejnmark L, Swart KMA, Brouwer IA, Lips P, van Schoor NM, Sempos CT, Durazo-Arvizu RA, Škrabáková Z, Dowling KG, Cashman KD, Kiely M, Pilz S, Gudnason V, Eiriksdottir G.

Nutrients. 2019 Jan 2;11(1). pii: E74. doi: 10.3390/nu11010074.

12.

Cardiovascular findings in patients with nonsurgical hypoparathyroidism and pseudohypoparathyroidism: A cohort study.

Underbjerg L, Sikjaer T, Rejnmark L.

Clin Endocrinol (Oxf). 2019 Apr;90(4):592-600. doi: 10.1111/cen.13927. Epub 2019 Jan 27.

PMID:
30589959
13.

Standards of Care for Hypoparathyroidism in Adults.

Khan AA, Koch C, Van Uum SHM, Baillargeon JP, Bollerslev J, Brandi ML, Marcocci C, Rejnmark L, Rizzoli R, Shrayyef MZ, Thakker RV, Yildiz BO, Clarke B.

Eur J Endocrinol. 2018 Dec 1. pii: EJE-18-0609.R1. doi: 10.1530/EJE-18-0609. [Epub ahead of print]

14.

MANAGEMENT OF ENDOCRINE DISEASE: Hypoparathyroidism in pregnancy: review and evidence-based recommendations for management.

Khan AA, Clarke B, Rejnmark L, Brandi ML.

Eur J Endocrinol. 2019 Feb 1;180(2):R37-R44. doi: 10.1530/EJE-18-0541. Review.

PMID:
30444723
15.

Bone Microstructure in Response to Vitamin D3 Supplementation: A Randomized Placebo-Controlled Trial.

Bislev LS, Langagergaard Rødbro L, Rolighed L, Sikjaer T, Rejnmark L.

Calcif Tissue Int. 2019 Feb;104(2):160-170. doi: 10.1007/s00223-018-0481-6. Epub 2018 Oct 6.

PMID:
30293198
16.

Health-related quality of life improves 1 year after parathyroidectomy in primary hyperparathyroidism: A prospective cohort study.

Ejlsmark-Svensson H, Sikjaer T, Webb SM, Rejnmark L, Rolighed L.

Clin Endocrinol (Oxf). 2019 Jan;90(1):184-191. doi: 10.1111/cen.13865. Epub 2018 Oct 22.

PMID:
30267589
17.

Effect of calcium citrate vs calcium carbonate on elevated parathyroid hormone after Roux-en-Y gastric bypass. A double-blinded, randomized trial.

Ring Madsen L, Espersen R, Rejnmark L, Richelsen B.

Clin Endocrinol (Oxf). 2018 Dec;89(6):734-741. doi: 10.1111/cen.13836. Epub 2018 Sep 5.

PMID:
30107042
18.

Rationale and Plan for Vitamin D Food Fortification: A Review and Guidance Paper.

Pilz S, März W, Cashman KD, Kiely ME, Whiting SJ, Holick MF, Grant WB, Pludowski P, Hiligsmann M, Trummer C, Schwetz V, Lerchbaum E, Pandis M, Tomaschitz A, Grübler MR, Gaksch M, Verheyen N, Hollis BW, Rejnmark L, Karras SN, Hahn A, Bischoff-Ferrari HA, Reichrath J, Jorde R, Elmadfa I, Vieth R, Scragg R, Calvo MS, van Schoor NM, Bouillon R, Lips P, Itkonen ST, Martineau AR, Lamberg-Allardt C, Zittermann A.

Front Endocrinol (Lausanne). 2018 Jul 17;9:373. doi: 10.3389/fendo.2018.00373. eCollection 2018. Review.

19.

The effect of vitamin D3 supplementation on markers of cardiovascular health in hyperparathyroid, vitamin D insufficient women: a randomized placebo-controlled trial.

Bislev LS, Langagergaard Rødbro L, Bech JN, Pedersen EB, Kjaergaard AD, Ladefoged SA, Rolighed L, Sikjaer T, Rejnmark L.

Endocrine. 2018 Oct;62(1):182-194. doi: 10.1007/s12020-018-1659-4. Epub 2018 Jul 24.

PMID:
30043092
20.

Dental Findings in Patients With Non-surgical Hypoparathyroidism and Pseudohypoparathyroidism: A Systematic Review.

Hejlesen J, Underbjerg L, Gjørup H, Bloch-Zupan A, Sikjaer T, Rejnmark L, Haubek D.

Front Physiol. 2018 Jun 19;9:701. doi: 10.3389/fphys.2018.00701. eCollection 2018.

21.

Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement.

Mantovani G, Bastepe M, Monk D, de Sanctis L, Thiele S, Usardi A, Ahmed SF, Bufo R, Choplin T, De Filippo G, Devernois G, Eggermann T, Elli FM, Freson K, García Ramirez A, Germain-Lee EL, Groussin L, Hamdy N, Hanna P, Hiort O, Jüppner H, Kamenický P, Knight N, Kottler ML, Le Norcy E, Lecumberri B, Levine MA, Mäkitie O, Martin R, Martos-Moreno GÁ, Minagawa M, Murray P, Pereda A, Pignolo R, Rejnmark L, Rodado R, Rothenbuhler A, Saraff V, Shoemaker AH, Shore EM, Silve C, Turan S, Woods P, Zillikens MC, Perez de Nanclares G, Linglart A.

Nat Rev Endocrinol. 2018 Aug;14(8):476-500. doi: 10.1038/s41574-018-0042-0. Review.

22.

Predictors of Renal Function and Calcifications in Primary Hyperparathyroidism: A Nested Case-Control Study.

Ejlsmark-Svensson H, Bislev LS, Rolighed L, Sikjaer T, Rejnmark L.

J Clin Endocrinol Metab. 2018 Sep 1;103(9):3574-3583. doi: 10.1210/jc.2018-00923.

PMID:
29955845
23.

Effects of Vitamin D3 Supplementation on Muscle Strength, Mass, and Physical Performance in Women with Vitamin D Insufficiency: A Randomized Placebo-Controlled Trial.

Bislev LS, Langagergaard Rødbro L, Rolighed L, Sikjaer T, Rejnmark L.

Calcif Tissue Int. 2018 Nov;103(5):483-493. doi: 10.1007/s00223-018-0443-z. Epub 2018 Jun 21.

PMID:
29931459
24.

Indoor, outdoor, and night work and blood concentrations of vitamin D and parathyroid hormone.

Daugaard S, Garde AH, Hansen ÅM, Vistisen HT, Rejnmark L, Kolstad HA.

Scand J Work Environ Health. 2018 Nov 1;44(6):647-657. doi: 10.5271/sjweh.3745. Epub 2018 Jun 17.

PMID:
29909424
25.

Effects of vitamin D supplementation on markers for cardiovascular disease and type 2 diabetes: an individual participant data meta-analysis of randomized controlled trials.

Swart KM, Lips P, Brouwer IA, Jorde R, Heymans MW, Grimnes G, Grübler MR, Gaksch M, Tomaschitz A, Pilz S, Eiriksdottir G, Gudnason V, Wamberg L, Rejnmark L, Sempos CT, Durazo-Arvizu RA, Dowling KG, Hull G, Škrabáková Z, Kiely M, Cashman KD, van Schoor NM.

Am J Clin Nutr. 2018 Jun 1;107(6):1043-1053. doi: 10.1093/ajcn/nqy078.

26.

Bioavailable Testosterone Is Positively Associated With Bone Mineral Density in Male Kidney Transplantation Candidates.

Jørgensen HS, Winther S, Bøttcher M, Hauge EM, Rejnmark L, Svensson M, Ivarsen P.

Kidney Int Rep. 2018 Feb 2;3(3):661-670. doi: 10.1016/j.ekir.2018.01.009. eCollection 2018 May.

27.

Prevalence and Risk of Vertebral Fractures in Primary Hyperparathyroidism: A Nested Case-Control Study.

Ejlsmark-Svensson H, Bislev LS, Lajlev S, Harsløf T, Rolighed L, Sikjaer T, Rejnmark L.

J Bone Miner Res. 2018 Sep;33(9):1657-1664. doi: 10.1002/jbmr.3461. Epub 2018 Jun 7.

28.

Effects of treatment with an angiotensin 2 receptor blocker and/or vitamin D3 on parathyroid hormone and aldosterone: A randomized, placebo-controlled trial.

Bislev LS, Langagergaard Rødbro L, Nørgaard Bech J, Bjerregaard Pedersen E, Rolighed L, Sikjaer T, Rejnmark L.

Clin Endocrinol (Oxf). 2018 Nov;89(5):656-666. doi: 10.1111/cen.13734. Epub 2018 May 23.

PMID:
29733445
29.

Pro-FHH: A Risk Equation to Facilitate the Diagnosis of Parathyroid-Related Hypercalcemia.

Bertocchio JP, Tafflet M, Koumakis E, Maruani G, Vargas-Poussou R, Silve C, Nissen PH, Baron S, Prot-Bertoye C, Courbebaisse M, Souberbielle JC, Rejnmark L, Cormier C, Houillier P.

J Clin Endocrinol Metab. 2018 Jul 1;103(7):2534-2542. doi: 10.1210/jc.2017-02773.

PMID:
29727008
30.

Sclerostin is not associated with cardiovascular event or fracture in kidney transplantation candidates
.

Jørgensen HS, Winther S, Dupont L, Bøttcher M, Rejnmark L, Hauge EM, Svensson M, Ivarsen P.

Clin Nephrol. 2018 Jul;90(1):18-26. doi: 10.5414/CN109333.

PMID:
29701175
31.

Non-parathyroid hypercalcemia associated with paraffin oil injection in 12 younger male bodybuilders: a case series.

Sølling ASK, Tougaard BG, Harsløf T, Langdahl B, Brockstedt HK, Byg KE, Ivarsen P, Ystrøm IK, Mose FH, Isaksson GL, Hansen MSS, Nagarajah S, Ejersted C, Bendstrup E, Rejnmark L.

Eur J Endocrinol. 2018 Jun;178(6):K29-K37. doi: 10.1530/EJE-18-0051. Epub 2018 Mar 29.

PMID:
29599408
32.

Role of Vitamin D in the Natural History of Inflammatory Bowel Disease.

Nielsen OH, Rejnmark L, Moss AC.

J Crohns Colitis. 2018 May 25;12(6):742-752. doi: 10.1093/ecco-jcc/jjy025. Review.

PMID:
29529167
33.

Long-Term Complications in Patients With Hypoparathyroidism Evaluated by Biochemical Findings: A Case-Control Study.

Underbjerg L, Sikjaer T, Rejnmark L.

J Bone Miner Res. 2018 May;33(5):822-831. doi: 10.1002/jbmr.3368. Epub 2018 Feb 14.

34.

Quality of life in hypoparathyroidism.

Rejnmark L.

Endocrine. 2018 Feb;59(2):237-238. doi: 10.1007/s12020-017-1479-y. Epub 2017 Nov 27. No abstract available.

PMID:
29181618
35.

Bone Status Among Patients With Nonsurgical Hypoparathyroidism, Autosomal Dominant Hypocalcaemia, and Pseudohypoparathyroidism: A Cohort Study.

Underbjerg L, Malmstroem S, Sikjaer T, Rejnmark L.

J Bone Miner Res. 2018 Mar;33(3):467-477. doi: 10.1002/jbmr.3328. Epub 2017 Nov 30.

36.

Hypoparathyroidism.

Mannstadt M, Bilezikian JP, Thakker RV, Hannan FM, Clarke BL, Rejnmark L, Mitchell DM, Vokes TJ, Winer KK, Shoback DM.

Nat Rev Dis Primers. 2017 Oct 5;3:17080. doi: 10.1038/nrdp.2017.80.

PMID:
28980621
37.

Bone turnover markers are associated with bone density, but not with fracture in end stage kidney disease: a cross-sectional study.

Jørgensen HS, Winther S, Bøttcher M, Hauge EM, Rejnmark L, Svensson M, Ivarsen P.

BMC Nephrol. 2017 Sep 6;18(1):284. doi: 10.1186/s12882-017-0692-5.

38.

Hypoparathyroidism.

Mannstadt M, Bilezikian JP, Thakker RV, Hannan FM, Clarke BL, Rejnmark L, Mitchell DM, Vokes TJ, Winer KK, Shoback DM.

Nat Rev Dis Primers. 2017 Aug 31;3:17055. doi: 10.1038/nrdp.2017.55. Review. Erratum in: Nat Rev Dis Primers. 2017 Oct 05;3:17080.

PMID:
28857066
39.

Non-skeletal health effects of vitamin D supplementation: A systematic review on findings from meta-analyses summarizing trial data.

Rejnmark L, Bislev LS, Cashman KD, Eiríksdottir G, Gaksch M, Grübler M, Grimnes G, Gudnason V, Lips P, Pilz S, van Schoor NM, Kiely M, Jorde R.

PLoS One. 2017 Jul 7;12(7):e0180512. doi: 10.1371/journal.pone.0180512. eCollection 2017. Review.

40.

Current Assays to Determine Free 25-Hydroxyvitamin D in Serum.

Malmstroem S, Rejnmark L, Imboden JB, Shoback DM, Bikle DD.

J AOAC Int. 2017 Sep 1;100(5):1323-1327. doi: 10.5740/jaoacint.17-0085. Epub 2017 May 11. Review.

PMID:
28492133
41.

Vitamin D and mortality: Individual participant data meta-analysis of standardized 25-hydroxyvitamin D in 26916 individuals from a European consortium.

Gaksch M, Jorde R, Grimnes G, Joakimsen R, Schirmer H, Wilsgaard T, Mathiesen EB, Njølstad I, Løchen ML, März W, Kleber ME, Tomaschitz A, Grübler M, Eiriksdottir G, Gudmundsson EF, Harris TB, Cotch MF, Aspelund T, Gudnason V, Rutters F, Beulens JW, van 't Riet E, Nijpels G, Dekker JM, Grove-Laugesen D, Rejnmark L, Busch MA, Mensink GB, Scheidt-Nave C, Thamm M, Swart KM, Brouwer IA, Lips P, van Schoor NM, Sempos CT, Durazo-Arvizu RA, Škrabáková Z, Dowling KG, Cashman KD, Kiely M, Pilz S.

PLoS One. 2017 Feb 16;12(2):e0170791. doi: 10.1371/journal.pone.0170791. eCollection 2017.

42.

Correlations Between Changes in Undercarboxylated Osteocalcin and Muscle Function in Hypoparathyroidism.

Harslof T, Sikjaer T, Mosekilde L, Langdahl BL, Rejnmark L.

Int J Endocrinol Metab. 2016 Aug 17;14(3):e38440. eCollection 2016 Jul.

43.

AP2S1 and GNA11 mutations - not a common cause of familial hypocalciuric hypercalcemia.

Hovden S, Rejnmark L, Ladefoged SA, Nissen PH.

Eur J Endocrinol. 2017 Feb;176(2):177-185. Epub 2016 Nov 15.

PMID:
27913609
44.

Effect of Intravenous Contrast on Volumetric Bone Mineral Density in Patients with Chronic Kidney Disease.

Jørgensen HS, Winther S, Bøttcher M, Thygesen J, Rejnmark L, Hauge EM, Svensson M, Ivarsen P.

J Clin Densitom. 2016 Oct;19(4):423-429. doi: 10.1016/j.jocd.2016.04.009. Epub 2016 May 9.

PMID:
27174315
45.

Association between bone indices assessed by DXA, HR-pQCT and QCT scans in post-menopausal women.

Amstrup AK, Jakobsen NF, Moser E, Sikjaer T, Mosekilde L, Rejnmark L.

J Bone Miner Metab. 2016 Nov;34(6):638-645. Epub 2015 Aug 21.

PMID:
26293682
46.

Multiple endocrine neoplasia phenocopy revealed as a co-occurring neuroendocrine tumor and familial hypocalciuric hypercalcemia type 3.

Hovden S, Jespersen ML, Nissen PH, Poulsen PL, Rolighed L, Ladefoged SA, Rejnmark L.

Clin Case Rep. 2016 Aug 18;4(10):922-927. eCollection 2016 Oct.

47.

Recurrence of Hyperparathyroid Hypercalcemia in a Patient With the HRPT-2 Mutation and a Previous Parathyroid Carcinoma in Hyperparathyroidism-Jaw Tumor Syndrome.

Mele M, Rolighed L, Jespersen M, Rejnmark L, Christiansen P.

Int J Endocrinol Metab. 2016 Apr 23;14(2):e35424. doi: 10.5812/ijem.35424. eCollection 2016 Apr.

48.

The cardiovascular system in familial hypocalciuric hypercalcemia: a cross-sectional study on physiological effects of inactivating variants in the calcium-sensing receptor gene.

Breum Jakobsen NF, Laugesen E, Rolighed L, Nissen PH, Poulsen PL, Pedersen EB, Mosekilde L, Rejnmark L.

Eur J Endocrinol. 2016 Oct;175(4):299-309. doi: 10.1530/EJE-16-0369. Epub 2016 Jul 14.

PMID:
27418061
49.

High Level of Agreement between Electronic and Paper Mode of Administration of a Thyroid-Specific Patient-Reported Outcome, ThyPRO.

Rasmussen SL, Rejnmark L, Ebbehøj E, Feldt-Rasmussen U, Rasmussen ÅK, Bjorner JB, Watt T.

Eur Thyroid J. 2016 Mar;5(1):65-72. doi: 10.1159/000443609. Epub 2016 Mar 4.

50.

Arterial Stiffness and Central Hemodynamics in Thyroidectomized Patients on Long-Term Substitution Therapy with Levothyroxine.

Laugesen E, Moser E, Sikjaer T, Poulsen PL, Rejnmark L.

Thyroid. 2016 Jun;26(6):779-84. doi: 10.1089/thy.2015.0600. Epub 2016 May 2.

PMID:
27029953

Supplemental Content

Loading ...
Support Center